Morten Lapin

Stavanger, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics.

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics.

Journal: Molecular oncology

Published: July 11, 2025

Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes.

Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes.

Journal: Frontiers in immunology

Published: October 07, 2024

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.

Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer.

Journal: PloS one

Published: May 15, 2023

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging.

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging.

Journal: Molecular oncology

Published: February 28, 2023

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer.

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 15, 2022

Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.

Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.

Journal: The oncologist

Published: June 09, 2022

Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors.

Monitoring of Dynamic Changes and Clonal Evolution in Circulating Tumor DNA From Patients With IDH-Mutated Cholangiocarcinoma Treated With Isocitrate Dehydrogenase Inhibitors.

Journal: JCO precision oncology

Published: February 16, 2022

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study.

Prognostic value of disseminated tumor cells in unresectable pancreatic ductal adenocarcinoma: a prospective observational study.

Journal: BMC cancer

Published: January 14, 2022

High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling.

High-Grade Cervical Intraepithelial Neoplasia (CIN) Associates with Increased Proliferation and Attenuated Immune Signaling.

Journal: International journal of molecular sciences

Published: December 01, 2021

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing.

Novel hybridization- and tag-based error-corrected method for sensitive ctDNA mutation detection using ion semiconductor sequencing.

Journal: Scientific reports

Published: November 22, 2021

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System.

Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System.

Journal: Cancers

Published: March 03, 2021

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.

Journal: Journal of translational medicine

Published: September 05, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026